A cancer-focused drug discoverer and developer emerged from stealth mode by disclosing today that it has raised $40 million in Series A and Series B financings.
http://www.genengnews.com/gen-news-highlights/cancer-focused-vivace-emerges-with-40m-in-financing/81254586
Cancer-Focused Vivace Emerges with $40M in Financing